Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Arenare, L.
90  Ergebnisse:
Personensuche X
?
1

Confirmatory validation analysis of the PROFFIT questionnai..:

Arenare, L ; Porta, C ; Barberio, D...
https://research.stmarys.ac.uk/id/eprint/6162/1/PIIS2059702923014333.pdf.  , 2023
Link: https://research.stmarys..
 
?
2

Alternative academic approaches for testing homologous reco..:

Capoluongo ED ; Pellegrino B ; Arenare L...
doi:10.1016/j.esmoop.2022.100585.  , 2022
Link: https://zenodo.org/recor..
 
?
3

Change in pediatric health care spending and drug utilizati..:

Lubrano R ; Del Giudice E ; Marcellino A...
info:eu-repo/semantics/altIdentifier/pmid/34943379.  , 2021
Link: http://hdl.handle.net/11..
 
?
4

Evaluation of angiogenesis-related genes as prognostic biom..:

Califano D ; Gallo D ; Vinciguerra G. L. R...
info:eu-repo/semantics/altIdentifier/pmid/34680301.  , 2021
Link: http://hdl.handle.net/11..
 
?
5

Chemotherapy-induced neutropenia and treatment efficacy in ..:

Gargiulo P ; Arenare L ; Gridelli C...
info:eu-repo/semantics/altIdentifier/pmid/33985435.  , 2021
Link: http://hdl.handle.net/23..
 
?
6

Correction to: Tocilizumab for patients with COVID-19 pneum..:

Perrone F ; Piccirillo M. C ; Ascierto P. A...
info:eu-repo/semantics/altIdentifier/wos/WOS:000709794700003.  , 2021
Link: https://hdl.handle.net/1..
 
?
7

Correction to: Tocilizumab for patients with COVID-19 pneum..:

Perrone F ; Piccirillo M. C ; Ascierto P. A...
info:eu-repo/semantics/altIdentifier/pmid/34674735.  , 2021
Link: http://hdl.handle.net/23..
 
?
8

Correction to: Tocilizumab for patients with COVID-19 pneum..:

Perrone F ; Piccirillo M. C ; Ascierto P. A...
info:eu-repo/semantics/altIdentifier/pmid/34674735.  , 2021
Link: http://hdl.handle.net/11..
 
?
9

Tocilizumab for patients with COVID-19 pneumonia. The singl..:

Perrone, F ; Piccirillo, MC ; Ascierto, PA...
info:eu-repo/semantics/altIdentifier/pmid/33087150.  , 2021
Link: http://hdl.handle.net/11..
 
?
10

Correction to: Tocilizumab for patients with COVID-19 pneum..:

Perrone F ; Piccirillo M. C ; Ascierto P. A...
info:eu-repo/semantics/altIdentifier/wos/WOS:000709794700003.  , 2021
Link: http://hdl.handle.net/11..
 
?
11

Correction to: Tocilizumab for patients with COVID-19 pneum..:

Perrone F ; Piccirillo M. C ; Ascierto P. A...
info:eu-repo/semantics/altIdentifier/pmid/34674735.  , 2021
Link: http://hdl.handle.net/11..
 
?
12

A qualitative analysis and development of a conceptual mode..:

Riva S ; Efficace F ; Di Maio M...
info:eu-repo/semantics/altIdentifier/pmid/33094357.  , 2021
Link: http://hdl.handle.net/23..
 
?
13

Olaparib as maintenance therapy in patients with BRCA 1–2 m..:

Cecere S. C ; Giannone G ; Salutari V...
info:eu-repo/semantics/altIdentifier/pmid/31699415.  , 2020
Link: http://hdl.handle.net/23..
 
?
14

Tocilizumab for patients with COVID-19 pneumonia. The singl..:

Perrone F ; Piccirillo M. C ; Ascierto P. A...
info:eu-repo/semantics/altIdentifier/pmid/33087150.  , 2020
Link: https://hdl.handle.net/1..
 
?
15

Tocilizumab for patients with COVID-19 pneumonia. The singl..:

Perrone F ; Piccirillo M. C ; Ascierto P. A...
info:eu-repo/semantics/altIdentifier/pmid/33087150.  , 2020
Link: http://hdl.handle.net/10..
 
1-15